Efficacy and safety of twice- or thrice-weekly dutasteride versus daily finasteride in men with androgenetic alopecia: A randomized, investigator-blinded, active-controlled, parallel-group pilot study.

JAAD Int · 2025 · PMC12547282 · PMID 41140354

Europe PMC DOI

hedged sentence

0.2300

closest p · 4.6× alpha

0.2300

boldest claim

The sentences

did not reach statistical significanceP = .23not close (p > 0.1)

When compared with FIN7, DU3 revealed a greater increase in hair growth whereas DU2 revealed a lesser increase; however, these differences did not reach statistical significance ( P = .23 and .27).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.